Adherence to statin or aspirin or both in patients with established cardiovascular disease: Exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome

British Journal of Clinical Pharmacology

Volumn 66, Issue 1, 2008, Pages 110-116

  Wei, Li ^a   Fahey, Tom ^b   MacDonald, Thomas M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Aspirin; Cardiovascular recurrence; Long term adherence; Statin

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

ASPIRIN; CARDIOVASCULAR DISEASES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PATIENT COMPLIANCE; RECURRENCE; SCOTLAND; TREATMENT OUTCOME;

EID: 44949186765     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03212.x     Document Type: Article

References (26)

1. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J 2006 151 : 185 91.
2. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007 297 : 177 86.
3. Strandberg TE, Lehto S, Pyorala K, Kesaniemi A, Oksa H. Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. Eur Heart J 1997 18 : 1725 7.
4. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002 288 : 495 7.
5. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002 288 : 462 7.
6. The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980 303 : 1038 41.
7. Wei L, Parkinson J, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO). In : Pharmacoepidemiology, 4th edn, ed. Strom BL. Chichester : John Wiley and Sons, 2005 323 36.
8. ISD Scotland. Data Quality Assurance. Available at http://www. isdscotland.org/isd/4943.html (last accessed: 7 May 2008).
9. Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med 1997 241 : 317 25.
10. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003 361 : 573 4.
11. Tsuyuki RT, Bungard TJ. Poor adherence with hypolipidemic drugs: a lost opportunity. Pharmacotherapy 2001 21 : 576 82.
12. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 2005 21 : 485 8.
13. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998 279 : 1458 62.
14. Larsen J, Andersen M, Kragstrup J, Gram LF. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol 2002 53 : 375 8.
15. Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care 1998 4 : 1421 30.
16. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998 279 : 1458 62.
17. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD : Johns Hopkins, 1979 516.
18. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002 88 : 229 33.
19. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. Review. BMJ 2006 333 : 15 8.
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997 336 : 973 9.
21. MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997 315 : 1333 7.
22. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999 282 : 2340 6.
23. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993 307 : 846 8.
24. Hennessy S, Carson JL, Ray WA, Strom BL. Medicaid databases. In : Pharmacoepidemiology, 4th edn, ed. Strom BL. Chichester : John Wiley & Sons, 2005 281 94.
25. Scottish Health Survey, 1995. Volume 1, Chapter 4 : Smoking. Edinburgh : The Stationery Office, 1997 140 1.
26. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, MacDonald TM. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002 11 : 329 31.